Skip to main content
Dr. Martens PLC logo

Dr. Martens PLC — Investor Relations & Filings

Ticker · DOCMF ISIN · GB00BL6NGV24 LEI · 213800QPT8YM6NQZPH28 IL Manufacturing
Open in API
Filings indexed 372 across all filing types
Latest filing 2024-02-05 Director's Dealing
Country GB United Kingdom
Listing IL DOCMF

About Dr. Martens PLC

https://www.drmartens.com

Dr. Martens PLC is an iconic global footwear brand with a heritage of over 60 years. The company designs, develops, procures, markets, and distributes footwear, recognized for its durability and distinctive style. Its products, particularly the original 1460 boot, are characterized by an air-cushioned sole (marketed as AirWair), grooved edges, and signature yellow welt stitching. Originally created as a durable work boot, the brand has evolved into a cultural icon, adopted by various subcultures and individuals worldwide as a symbol of rebellious self-expression and authenticity. The company sells its products to consumers in more than 60 countries through a multi-channel distribution strategy.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is an official notification disseminated via RNS (RNS Number : 0641C) on 05 February 2024. The title explicitly states 'Notification of Transactions by Directors/Persons Discharging Managerial Responsibility' and details share acquisitions by the CEO (Kenny Wilson) and CFO (Jon Mortimore) under the Share Incentive Plan (SIP). This content directly corresponds to the definition of Director's Dealing (insider trades by executives). The filing code for this specific type of disclosure is DIRS.
2024-02-05 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short regulatory announcement released via RNS (London Stock Exchange's news service) on February 1, 2024. The content explicitly states the 'Total Voting Rights' (961,611,164 shares) as required by the FCA's Disclosure Guidance and Transparency Rule 5.6.1. This type of mandatory disclosure regarding the total number of shares with voting rights, released through an official news service like RNS, fits best under the general 'Regulatory Filings' category, as there is no specific code for 'Total Voting Rights' disclosure, and it is not a report itself (per the 'MENU VS MEAL' rule, although this is an announcement, it is a specific regulatory filing type). Given the context of RNS distribution and the nature of the disclosure (voting rights denominator), RNS is the most appropriate general classification.
2024-02-01 English
Q3 FY24 Trading Statement
Earnings Release Classification · 99% confidence The document is identified by the header 'RNS Number : 8274A' and the footer stating, 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates it is a regulatory announcement disseminated via the RNS system. The content is titled 'Trading statement for the three months ended 31 December 2023' and provides key financial highlights (revenue figures, YoY changes) and outlook commentary for the third quarter (Q3). This structure aligns perfectly with an Earnings Release (ER), which is the initial announcement of periodical financial results (key highlights only). It is not a comprehensive Interim Report (IR) or Annual Report (10-K), nor is it merely an announcement of a report (RPA), as it contains the actual trading data and commentary. The presence of a conference call announcement further supports the ER classification. Q3 2024
2024-01-25 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is identified by the 'RNS Number' header and contains a notification regarding 'Transactions by Directors/Persons Discharging Managerial Responsibility (PDMR)'. It details the purchase of shares by executives (Kenny Wilson and Jon Mortimore) under a Share Incentive Plan (SIP) and cites Article 19 of the UK Market Abuse Regulation. This specific type of insider transaction reporting by directors falls directly under the definition of Director's Dealing.
2024-01-12 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official notification released via RNS (London Stock Exchange's news service) under the RNS Number 3619Y. The content explicitly states the 'Total Voting Rights' as required by the FCA's Disclosure Guidance and Transparency Rule 5.6.1. This type of announcement, which provides a specific, required regulatory figure (total shares with voting rights) for shareholders to use in their own disclosures, fits best under the general regulatory announcement category. While it relates to voting rights, it is not the declaration of results (DVA) but a prerequisite disclosure. Given its nature as a standard, required regulatory update provided through the RNS system, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory disclosure that doesn't fit the more specific categories like DIV, DVA, or MANG.
2024-01-02 English
Transaction in Own Shares
Transaction in Own Shares Classification · 99% confidence The document explicitly announces 'TRANSACTIONS IN OWN SECURITIES & CONCLUSION OF BUYBACK' by Dr. Martens plc. It details the number of ordinary shares purchased, the prices paid, and confirms that these purchases conclude the existing share buyback programme. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchase activities. The presence of the RNS Number and the closing statement referencing RNS confirms it is a regulatory announcement, but the specific content points overwhelmingly to POS.
2023-12-15 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.